PNC Financial Services Group’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4K Sell
1,387
-34
-2% -$429 ﹤0.01% 3796
2025
Q4
$23.6K Sell
1,421
-127
-8% -$1.81K ﹤0.01% 3589
2025
Q3
$18.2K Buy
1,548
+201
+15% +$2.07K ﹤0.01% 3682
2025
Q2
$12.9K Buy
1,347
+1,037
+335% +$5.74K ﹤0.01% 3763
2025
Q1
$1.94K Buy
310
+37
+14% +$225 ﹤0.01% 4353
2024
Q4
$2.22K Hold
273
﹤0.01% 4254
2024
Q3
$4.94K Buy
273
+122
+81% +$1.71K ﹤0.01% 4043
2024
Q2
$1.55K Sell
151
-15
-9% -$154 ﹤0.01% 4321
2024
Q1
$1.76K Buy
166
+31
+23% +$263 ﹤0.01% 4230
2023
Q4
$1.23K Buy
135
+5
+4% +$43 ﹤0.01% 4280
2023
Q3
$1.35K Buy
+130
New +$1.78K ﹤0.01% 4320
2020
Q4
Sell
-85
Closed -$3K 4041
2020
Q3
$3K Hold
85
﹤0.01% 3765
2020
Q2
$3K Hold
85
﹤0.01% 3727
2020
Q1
$2K Hold
85
﹤0.01% 3743
2019
Q4
$3K Buy
+85
New +$2.14K ﹤0.01% 3738

Other funds holding PHAT